Acquisition Opportunity MDA was acquired by RTI International, indicating potential integration of GHEOR chart study capabilities with larger RWE and health economics resources. This suggests opportunities to position co-branded or RTI-aligned offerings to leverage broader distribution and credibility.

RWE Growth Specialization in real-world evidence generation and chart studies aligns with rising demand in pharma and biotech for observational data, registry designs, and patient outcomes to support trial design, market access, and safety.

Small Firm Agility With a lean team and revenue under one million, MDA offers potential for scalable, modular service packages, quick deployment, and targeted engagements that complement larger vendors by filling niche GHEOR chart study needs.

Tech Stack Fit Current technology stack (Joomla, MooTools, jQuery, PHP) highlights opportunities for modernization partnerships or migration projects and for delivering cost-effective web-enabled chart study platforms and registries.

Targeted Markets Serving life-sciences clients from startups to multinationals positions MDA to pursue tiered proposals, partner with larger CROs for niche chart study work, and expand market access and outcomes research offerings to current and prospective customers.